
CAS 343787-29-1
:CP 673451
Description:
CP 673451 is a small molecule that acts as a selective inhibitor of certain receptor tyrosine kinases, particularly those involved in the signaling pathways of cancer cell proliferation and survival. It is primarily studied for its potential therapeutic applications in oncology, particularly in targeting tumors that exhibit aberrant signaling through these kinases. The compound is characterized by its ability to interfere with the ATP-binding site of the target kinases, thereby inhibiting their activity and downstream signaling cascades. CP 673451 has shown promise in preclinical studies, demonstrating efficacy in various cancer models. Its chemical structure includes specific functional groups that contribute to its binding affinity and selectivity. As with many investigational drugs, the pharmacokinetics, metabolism, and safety profile of CP 673451 are critical areas of research, as they determine its viability for clinical use. Ongoing studies aim to elucidate its full therapeutic potential and any associated side effects in the context of cancer treatment.
Formula:C24H27N5O2
Synonyms:- 1-[2-[5-(2-Methoxyethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-ylamine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
1-(2-(5-(2-methoxyethoxy)benzimidazol-1-yl)quinolin-8-yl)piperidin-4-ylamine
CAS:Formula:C24H27N5O2Purity:99%Color and Shape:SolidMolecular weight:417.50351 - (2 - (5 - (2-Methoxyethoxy) - 1H-Benzo [D] Imidazol-1-Yl) Quinoline-8-Yl) Piperidin-4-Amine
CAS:1 - (2 - (5 - (2-Methoxyethoxy) - 1H-Benzo [D] Imidazol-1-Yl) Quinoline-8-Yl) Piperidin-4-AminePurity:97%Molecular weight:417.5g/molCP-673451
CAS:CP-673451 is a specific inhibitor of PDGFRα/β (IC50: 10/1 nM) with antiangiogenic and antitumor activity and the selectivity is higher 450-fold than otherFormula:C24H27N5O2Purity:99.62% - 99.88%Color and Shape:SolidMolecular weight:417.5


